Alyeska Investment Group’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-147,458
| Closed | -$96K | – | 574 |
|
2017
Q3 | $96K | Buy |
+147,458
| New | +$96K | ﹤0.01% | 420 |
|
2017
Q1 | – | Sell |
-147,458
| Closed | -$102K | – | 608 |
|
2016
Q4 | $102K | Hold |
147,458
| – | – | ﹤0.01% | 433 |
|
2016
Q3 | $209K | Hold |
147,458
| – | – | ﹤0.01% | 424 |
|
2016
Q2 | $240K | Hold |
147,458
| – | – | ﹤0.01% | 405 |
|
2016
Q1 | $314K | Sell |
147,458
-43,043
| -23% | -$91.7K | ﹤0.01% | 363 |
|
2015
Q4 | $739K | Sell |
190,501
-31,393
| -14% | -$122K | 0.01% | 342 |
|
2015
Q3 | $763K | Buy |
221,894
+13,935
| +7% | +$47.9K | 0.01% | 400 |
|
2015
Q2 | $1.03M | Buy |
207,959
+52,558
| +34% | +$260K | 0.01% | 386 |
|
2015
Q1 | $763K | Sell |
155,401
-34,897
| -18% | -$171K | 0.01% | 423 |
|
2014
Q4 | $790K | Sell |
190,298
-7,048
| -4% | -$29.3K | 0.01% | 395 |
|
2014
Q3 | $1.14M | Sell |
197,346
-9,337
| -5% | -$53.7K | 0.02% | 303 |
|
2014
Q2 | $1.43M | Buy |
+206,683
| New | +$1.43M | 0.03% | 303 |
|